Cargando…

Efficacy of Onabotulinum Toxin A (Botox) versus Abobotulinum Toxin A (Dysport) Using a Conversion Factor (1 : 2.5) in Treatment of Primary Palmar Hyperhidrosis

Background. Two preparations of botulinum A toxin (BTX-A) are commercially available for the treatment of palmar hyperhidrosis (PPH): Botox (Allergan; 100 U/vial) and Dysport (Ipsen Limited; 500 U/vial), which are not bioequivalent. Results regarding an appropriate conversion factor between them are...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Kahky, Hanan Mohamed, Diab, Heba Mahmoud, Aly, Dalia Gamal, Farag, Nehal Magdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819791/ https://www.ncbi.nlm.nih.gov/pubmed/24250334 http://dx.doi.org/10.1155/2013/686329

Ejemplares similares

Onabotulinum Toxin A (Botox®) in the Treatment of Neurogenic Bladder Overactivity
por: Rohrsted, Malene, et al.
Publicado: (2012)

Onabotulinum toxin-A (Botox) for spastic equinus in cerebral palsy: a prospective kinematic study
por: Hastings-Ison, T., et al.
Publicado: (2018)

Conversion Ratio between Botox(®), Dysport(®), and Xeomin(®) in Clinical Practice
por: Scaglione, Francesco
Publicado: (2016)

Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain
por: Machado, Duarte, et al.
Publicado: (2016)

Content of Botulinum Neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®
por: Frevert, Jürgen
Publicado: (2012)

Patients profiling for Botox® (onabotulinum toxin A) treatment for migraine: a look at white matter lesions in the MRI as a potential marker
por: Bumb, Anja, et al.
Publicado: (2013)

The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud’s Phenomenon: A Case Series
por: Winter, Amelia R, et al.
Publicado: (2020)

Real-World Evaluation of the Tolerability to Onabotulinum Toxin A: The RETO Study
por: García-Azorín, David, et al.
Publicado: (2022)

Onabotulinum toxin A vs. incobotulinum toxin A for the treatment of chronic migraine: a retrospective review
por: Lucchese, Scott, et al.
Publicado: (2023)

Economic Evaluation of Botulinum Toxin Versus Thoracic Sympathectomy for Palmar Hyperhidrosis: Data from a Real-World Scenario
por: Isla-Tejera, Beatriz, et al.
Publicado: (2013)

Alternative Surgical Methods in Patients with Recurrent Palmar Hyperhidrosis and Compensatory Hyperhidrosis
por: Jung, Hee Suk, et al.
Publicado: (2018)

Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations
por: Barbanti, Piero, et al.
Publicado: (2017)

The Role of Onabotulinum Toxin Type A in the Management of Chronic Non-migraine Headaches
por: Jia, Cassie, et al.
Publicado: (2019)

Measuring Effects on Pain and Quality of Life after Abobotulinum Toxin A Injections in Children with Cerebral Palsy
por: Wong, Christian, et al.
Publicado: (2022)

A comparative trial of ice application versus EMLA cream in alleviation of pain during botulinum toxin injections for palmar hyperhidrosis
por: Alsantali, Adel
Publicado: (2018)

Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): Development, insights, and impact
por: Lowe, Nicholas, et al.
Publicado: (2023)

Management Strategies Of Palmar Hyperhidrosis: Challenges And Solutions
por: Gregoriou, Stamatios, et al.
Publicado: (2019)

Efficacy, Safety and Quality of Life of Oxybutynin versus Aluminum Chloride Hexahydrate in Treating Primary Palmar Hyperhidrosis
por: Attallah, Heba Shawky, et al.
Publicado: (2022)

Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation
por: Trinh, Hamilton, et al.
Publicado: (2019)

Dysport and Botox at a Ratio of 2.5:1 Units in Cervical Dystonia: A Double-Blind, Randomized Study
por: Yun, Ji Young, et al.
Publicado: (2015)

Single incision thoracoscopic sympathectomy for palmar and axillary hyperhidrosis
por: Baram, Aram
Publicado: (2014)

Palmar hyperhidrosis: clinical, pathophysiological, diagnostic and therapeutic aspects
por: Romero, Flávio Ramalho, et al.
Publicado: (2016)

Association between Reflux Esophagitis Incidence and Palmar Hyperhidrosis
por: Cheng, Chun-Gu, et al.
Publicado: (2020)

Increased Incidence of Premenstrual Syndrome in Females with Palmar Hyperhidrosis
por: Cheng, Chun-An, et al.
Publicado: (2021)

A Practical Approach to the Diagnosis and Treatment of Palmar Hyperhidrosis
por: Solish, Max J., et al.
Publicado: (2022)

A retrospective cohort study of T3 versus T4 thoracoscopic sympathectomy for primary palmar hyperhidrosis and primary palmar hyperhidrosis with axillary and plantar sweating
por: Xie, Hongya, et al.
Publicado: (2019)

AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients
por: Field, Malgorzata, et al.
Publicado: (2018)

EHMTI-0278. Onabotulinum toxin a for hemicrania continua: a case series of 8 patients
por: Miller, S, et al.
Publicado: (2014)

Further Evidence that Onabotulinum Toxin is a Viable Treatment Option for Pediatric Chronic Migraine Patients
por: Ali, Sameer S, et al.
Publicado: (2019)

New Injection Points of Onabotulinum Toxin A for Spastic Paralysis of the Fingers: Eight Cases of Report
por: Yamada, Shoko Merrit, et al.
Publicado: (2020)

Efficacy of Onabotulinum Toxin A on Obsessive–Compulsive Traits in a Population of Chronic Migraine Patients
por: Viticchi, Giovanna, et al.
Publicado: (2022)

The minimum effective dose of abobotulinum toxin A injection for allergic rhinitis: A dose‐escalation randomized controlled trial
por: Piromchai, Patorn, et al.
Publicado: (2020)

Anxiety after Sympathectomy in patients with primary palmar hyperhidrosis may prolong the duration of compensatory hyperhidrosis
por: Qian, Kai, et al.
Publicado: (2018)

Pulsed radiofrequency stimulation suppresses palmar hyperhidrosis in an animal study
por: Lin, Mu‐Lien, et al.
Publicado: (2017)

Comparison of T2 and T3 sympathectomy for compensatory sweating on palmar hyperhidrosis
por: Turkyilmaz, Atila, et al.
Publicado: (2017)

Minimally Invasive Sympathicotomy for Palmar Hyperhidrosis and Facial Blushing: Current Status and the Hyperhidrosis Expert Center Approach
por: Kuijpers, Michiel, et al.
Publicado: (2022)

Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study
por: Kongsaengdao, Subsai, et al.
Publicado: (2018)

Hyperhidrosis: Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum Toxins
por: Lakraj, Amanda-Amrita D., et al.
Publicado: (2013)

Pelvic-Spinal Analysis and the Impact of Onabotulinum toxin A Injections on Spinal Balance in one Child With Cerebral Palsy
por: Chaléat-Valayer, Emmanuelle, et al.
Publicado: (2016)

The Effects of Thoracic Sympathotomy on Heart Rate Variability in Patients with Palmar Hyperhidrosis
por: Zhang, Tong-yuan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ql37abah63hl247h5akvki5vq3